German-based Omicron designs and produces microscopes and chemical analysis instruments for nanotechnology research. Texas-based Ombiprobe designs and produces tools which give customers nano-scale laboratory capabilities within microscopes.

According to a statement, the combination of Oxford Instruments and the acquired businesses strengthens its Nanotechnology Tools sector through the addition of complementary portfolio of products and technologies.

‘I’m delighted with these acquisitions,’ says chief executive of UK-headquartered Oxford Instruments, Jonathan Flint.

‘[They] augment our growing ability to offer a suite of tools that help our customers benefit from the opportunities offered by nanotechnology.’

Omicron reported generated earnings before interest and tax (EBIT) of €3.2 million for the year ending 31 December 2010 from revenues of €37.9 million. Oxford Instruments is to pay €32.4 million for the business.

Omniprobe’s EBIT for the year ending 31 March 2011 were reported to be €1.18 million from a revenue of €6.31 million. The business has been acquired for an initial €13.3 million with a deferred € 554,000 payable in two years based on terms of the agreement.

Oxford Instruments says the purchased businesses share a similar customer base and routes to market with its existing companies, with the acquisitions bringing opportunities for the development of integrated new products.